Linked e-resources

Details

Section I: General Considerations
Chapter 1: Pharmacogenetics of Cutaneous Adverse Drug Reactions
Chapter 2: Mechanisms of Drug Hypersensitivity
Chapter 3: Histopathology of Cutaneous Adverse Drug Reactions
Chapter 4: Skin Tests in Evaluating Drug Eruptions
Chapter 5: In vitro Drug Allergy Testing
Section II: Reaction Patterns
Chapter 6: Drug-induced urticaria
Chapter 7: Exanthematous Drug Eruptions
Chapter 8: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Chapter 9: Acute Generalized Exanthematous Pustulosis
Chapter 10: Drug Reaction Eosinophilia and Systemic Symptoms (DRESS)
Chapter 11: Fixed Drug Eruptions and Generalized Bullous Fixed Drug Eruptions
Chapter 12: Lichenoid Drug Eruptions
Chapter 13: Drug-induced Connective Tissue Disorders
Chapter 14: Drug-induced Vasculitis
Chapter 15: Drug-induced Autoimmune Bullous Diseases
Chapter 16: Other Drug-induced Inflammatory Skin Reactions
Chapter 14: Drug-induced Vasculitis
Chapter 15: Drug-induced Autoimmune Bullous Diseases
Chapter 16: Other Drug-induced Inflammatory Skin Reactions
Chapter 17: Drug-induced Photosensitivity
Chapter 18: Drug-induced Pruritus Without Primary Rash
Chapter 19: Drug-induced Nail Changes
Chapter 20: Drug-induced Hair Changes
Chapter 21: Drug-induced Pigmentary Disorders
Section III: Special Drug Categories
Chapter 22: Immediate and Delayed Reactions to Beta-lactams
Chapter 23: Hypersensitivity Reactions to Iodinated Radiocontrast Media
Chapter 24: Cutaneous Adverse Reactions to Biologic Agents
Chapter 25: Cutaneous Reactions to Oncologic Targeted Therapy
Chapter 26 :Cutaneous Reactions to Oncologic Immunotherapy. .

Browse Subjects

Show more subjects...

Statistics

from
to
Export